Skip to main content

Day: August 16, 2021

K92 Mining Releases Strong Q2 Financial Results and Record Mill Throughput

VANCOUVER, British Columbia, Aug. 16, 2021 (GLOBE NEWSWIRE) — K92 Mining Inc. (“K92” or the “Company”) (TSX: KNT; OTCQX: KNTNF) is pleased to announce results from its financial statements for the three and six months ended June 30, 2021. SafetyStrong focus on safety with one of the best safety records in the Australasia region since start of operations. Proactive and focused management of COVID-19. K92 continues to operate and has strong preventative and response plans, with pandemic resiliency rapidly increasing through ongoing vaccination programs.ProductionRecord quarterly tonnage of 75,667 tonnes treated, a 53% increase from Q2 2020. Quarterly gold equivalent (“AuEq”) production of 25,015 oz, or 22,153 oz gold, 1,098,730 lbs copper and 14,914 oz silver. Cash costs of US$736/oz gold and all-in sustaining costs (“AISC”)...

Continue reading

MCI Onehealth Reports Second Quarter 2021 Financial Results

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATESQuarterly revenue of $11.2 million up 53% over the same period last year, driven by the recovery of publicly insured health services and continued strong performance from corporate health customers Demand from corporate customers continues to grow, with revenues from corporate customers up more than 80% to $1.87 million over the same quarter last year and nearly 500 corporate customers on board at the end of the second quarter The company continues to focus on accretive acquisitions, investments in strategic partners and forming commercial partnerships to leverage advanced technology to improve healthcare services, including $12.6 million acquisition of Khure Health Inc. Addition of seasoned Chief Innovation Officer to lead the company’s innovation,...

Continue reading

Erdene Announces Q2 2021 Financial Results and Provides Bayan Khundii Gold Project Update

HALIFAX, Nova Scotia, Aug. 16, 2021 (GLOBE NEWSWIRE) — Erdene Resource Development Corp. (TSX:ERD; MSE:ERDN) (“Erdene” or the “Company”) is pleased to announce operating and financial results for the three months ended June 30, 2021, and to provide an update on its Bayan Khundii Gold Project (“Bayan Khundii” or “BK”), including the results of an updated Mineral Resource Estimate. This release should be read in conjunction with the Company’s Q2 2021 Financial Statements and MD&A, available on the Company’s website or SEDAR. Highlights:Recent exploration results indicate Bayan Khundii, Ulaan, and Dark Horse Mane are part of a large-scale, gold mineralized systemSignificant gold discovery at 100%-owned Ulaan, 300 metres west of the Bayan Khundii Gold deposit Multiple holes intersected high-grade mineralization...

Continue reading

Solid Biosciences Provides Second Quarter 2021 Business Update and Financial Results

– Clinical activities underway to advance patient dosing in IGNITE DMD; next patient dosing anticipated in Q4 2021 – – Development activities continue for pipeline initiatives SGT-003 and Ultragenyx collaboration, next generation gene therapy programs for Duchenne patients – – Company ends Q2 with approximately $249 million cash and investments; cash runway into Q4 2022 – CAMBRIDGE, Mass., Aug. 16, 2021 (GLOBE NEWSWIRE) — Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy (Duchenne), today provided a second quarter 2021 business update as well as financial results for the quarter ended June 30, 2021. “We continue on our mission of developing meaningful treatments for patients with Duchenne,” said Ilan Ganot,...

Continue reading

XpresSpa Group Announces Second Quarter 2021 Financial Results and Provides Business Update

Record MSA Practice Patient Fees Increases to $17.1 Million in Q2 against $6.3 Million in Q1 Net revenue of $9.1 Million, including $8.7 Million from XpresCheck™ Net Loss Narrows to $4.7 Million Compared to Net Loss of $58.5 Million in Prior Year Second Quarter Strong Liquidity Position with Unrestricted Cash Balance of $102.5 Million Re-opening an Additional Eight to Ten Legacy XpresSpa Locations this Fall Launched Phase 2 of Treat™ Today – Mobile App Launching Phase 3 of Treat this Fall – Locations in New York JFK International Airport and Phoenix Sky Harbor Airport Webcast and Conference Call Scheduled for 4:30 PM ET Today NEW YORK, Aug. 16, 2021 (GLOBE NEWSWIRE) — XpresSpa Group, Inc. (Nasdaq: XSPA), a travel health and wellness company, today announced that it has filed financial results on Form 10-Q for the second quarter...

Continue reading

LM Funding Reports Net Income of $11.1 Million or $2.05 Per Basic Common Share for the Second Quarter of 2021

TAMPA, Fla., Aug. 16, 2021 (GLOBE NEWSWIRE) — LM Funding America, Inc. (NASDAQ:LMFA) (“LM Funding” or “LMFA”), a technology-based specialty finance company, today announced its financial results for the three and six months ended June 30, 2021. Financial Highlights for the Three and Six Month Period Ended June 30, 2021:Net income attributable to LM Funding for the three and six-month periods ended June 30, 2021 totaled $11.1 million or $2.05 per basic and diluted share and $15.5 million or $2.96 per basic and $2.95 per diluted share, respectively. Cash increased to $22.2 million or approximately $4.09 per basic and diluted share on June 30, 2021 as compared to $11.6 million on December 31, 2020. Working capital as of June 30, 2021 was $29.7 million or $5.49 per basic and diluted share. As of August 6,...

Continue reading

Rockwell Medical, Inc. Provides Second Quarter 2021 Financial and Operational Update

-Entered into exclusive license agreement with Drogsan Pharmaceuticals for the rights to commercialize Triferic® in Turkey- -Extended multi-year distribution agreement with Nipro Medical for dialysis concentrates in LATAM and the Caribbean- -Q2 2021 conference call and webcast scheduled for today at 4:30 p.m. ET- WIXOM, Mich., Aug. 16, 2021 (GLOBE NEWSWIRE) — Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world, today reported financial results and a business update for the three months ended June 30, 2021. “We made significant progress in the second quarter on a number of fronts to develop and deliver innovative treatment to patients with iron...

Continue reading

Nova LifeStyle, Inc. Reports Second Quarter FY 2021 Results

LOS ANGELES, Aug. 16, 2021 (GLOBE NEWSWIRE) — Nova LifeStyle, Inc. (NASDAQ: NVFY) (“Nova LifeStyle” or the “Company”) today announced its financial results for the second quarter ended June 30, 2021. Key Financial Highlights: Operating Results for the Three Months Ended June 30, 2021Net sales for three months ended June 30, 2021 were $3.6 million, an increase of 55% from $2.3 million in the same period of 2020. Gross profit (loss) was ($4.0 million), compared to $0.9 million profit in the same period of 2020. The gross profit (loss) for the period ended June 30, 2021 exclusive of the write-down for slow moving inventory of $5.53 million, would have been $1.5 million. Net loss was ($6.3 million), compared to ($0.5 million) loss in the same period of 2020.Operating Results for the Six Months Ended June 30, 2021Net sales for...

Continue reading

Telos Corporation Reports Strong Second Quarter Results Driven by Growth in Xacta, Telos Ghost and Secure Networks; Delivers Gross Margin Expansion and Positive Cash Flow; Reaffirms Full Year Guidance

Delivers Revenues of $52.6 million; Up 8% Reported; Up 48% Excluding Contract with U.S. Census Bureau; Reports Double Digit Growth in Xacta, Telos Ghost, and Secure Networks Increases Gross Profit 17% to $20.6 Million; Expands Gross Margin 290 Basis Points to 39.1% Generates $3.5 Million of Cash Flow from Operations Reaffirms 2021 Sales Guidance of $283 million – $295 million and Adjusted EBITDA Guidance of $33 million – $36 millionASHBURN, Va., Aug. 16, 2021 (GLOBE NEWSWIRE) — Telos® Corporation (NASDAQ: TLS), a leading provider of cyber, cloud and enterprise security solutions for the world’s most security-conscious organizations, today announced financial results for the second quarter 2021. “We delivered a solid second quarter, as we continued to deliver revenue growth and win meaningful, large-scale contracts...

Continue reading

Atlas Technical Consultants Reports Second Quarter 2021 Results

– Delivered 17% Revenue Growth – – Completed Accretive Acquisitions of Atlantic Engineering Laboratories and O’Neill Service Group – – Increased Cash Flows from Operations – – Reiterated 2021 Outlook for Revenues and Adjusted EBITDA – AUSTIN, Texas, Aug. 16, 2021 (GLOBE NEWSWIRE) — Atlas Technical Consultants, Inc. (Nasdaq: ATCX) (“Atlas” or the “Company”), a leading infrastructure and environmental services provider, announced today results for the second quarter ended July 2, 2021. Second Quarter 2021 Highlights:Gross revenue grew 17% to $131.6 million, compared to $112.7 million in the prior-year quarter. Revenue growth was driven by continued solid execution across all of the Company’s services and included organic growth and contributions from the recent acquisitions. Net...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.